Indolylarylsulfones are a potent class of human immunodeficiency virus type 1 non-nucleoside reverse transcriptase inhibitors. In this review, the structure activity relationship (SAR) studies to improve the profile of sulfone L-737,126 discovered by Merck AG have been analysed with focus on introduction of the 3',5'-dimethyl groups at the 3-phenylsulfonyl moiety, the 2-hydroxyethyl tail at the indole-2-carboxamide nitrogen, coupling of the carboxamide nitrogen with one or two glycinamide and alaninamide units, a fluorine atom at position 4 of the indole ring and correlation between configuration of the asymmetric centre and linker length. IAS derivatives look like promising drug candidates for the treatment of AIDS and related infections in combination with other antiretroviral agents.
Keyphrases
- human immunodeficiency virus
- structure activity relationship
- antiretroviral therapy
- hepatitis c virus
- hiv infected
- hiv aids
- hiv positive
- hiv infected patients
- anti inflammatory
- quantum dots
- computed tomography
- highly efficient
- replacement therapy
- case control
- men who have sex with men
- adverse drug
- electronic health record